147 related articles for article (PubMed ID: 30917423)
1. [Comparison of different serological methods in screening early gastric cancer].
Ni DQ; Lyu B; Bao HB; Jin HF; Zhao J; Xu Y; Huang X
Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):294-300. PubMed ID: 30917423
[No Abstract] [Full Text] [Related]
2. [A comparative study of new gastric cancer screening scoring system and new ABC method for screening gastric cancer and precancerous lesions].
Wang XT; Ji ZZ; Han F; Lyu B
Zhonghua Nei Ke Za Zhi; 2021 Mar; 60(3):227-232. PubMed ID: 33663171
[No Abstract] [Full Text] [Related]
3. [Comparison of two serological methods in screening gastric cancer and its precancerous condition].
Li MY; Zhang DQ; Lu X; Chen WC
Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):907-911. PubMed ID: 30486559
[No Abstract] [Full Text] [Related]
4. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
Hamashima C; Sasazuki S; Inoue M; Tsugane S;
BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
[TBL] [Abstract][Full Text] [Related]
5. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for
Wang SS; Guo ZP; Zhao XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665
[TBL] [Abstract][Full Text] [Related]
7. Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.
Yamaguchi Y; Nagata Y; Hiratsuka R; Kawase Y; Tominaga T; Takeuchi S; Sakagami S; Ishida S
Digestion; 2016; 93(1):13-8. PubMed ID: 26789514
[TBL] [Abstract][Full Text] [Related]
8. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
[TBL] [Abstract][Full Text] [Related]
9. Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test-negative individuals.
Sheng C; Sun L; Lyu Z; Li L; Zhang Y; Zhang Y; Zhang Y; Dai H; Huang Y; Song F; Yuan Y; Chen K
Helicobacter; 2023 Jun; 28(3):e12966. PubMed ID: 36941759
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of the normal range of gastrin calculated using strict criteria based on a combination of serum markers and pathological evaluation for detecting gastritis: a retrospective study.
Nagasaki N; Takigawa H; Ito M; Boda T; Kotachi T; Hayashi R; Yuge R; Urabe Y; Oka S; Tanaka S
BMC Gastroenterol; 2023 May; 23(1):167. PubMed ID: 37210509
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan.
Saito S; Azumi M; Muneoka Y; Nishino K; Ishikawa T; Sato Y; Terai S; Akazawa K
Eur J Health Econ; 2018 May; 19(4):545-555. PubMed ID: 28550494
[TBL] [Abstract][Full Text] [Related]
12. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
[TBL] [Abstract][Full Text] [Related]
13. Clinical applicability of a new scoring system for population-based screening and risk factors of gastric cancer in the Wannan region.
Li L; Ni J; Sun S; Zha X; Li R; He C
BMC Gastroenterol; 2022 Jun; 22(1):306. PubMed ID: 35739473
[TBL] [Abstract][Full Text] [Related]
14. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
15. The new modified ABCD method for gastric neoplasm screening.
Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Nishida J
Anticancer Res; 2015 Dec; 35(12):6765-71. PubMed ID: 26637894
[TBL] [Abstract][Full Text] [Related]
17. Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.
Kotachi T; Ito M; Yoshihara M; Boda T; Kiso M; Masuda K; Matsuo T; Tanaka S; Chayama K
Digestion; 2017; 95(4):314-318. PubMed ID: 28571035
[TBL] [Abstract][Full Text] [Related]
18. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
[TBL] [Abstract][Full Text] [Related]
19. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
20. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
Boda T; Ito M; Yoshihara M; Kitamura Y; Matsuo T; Oka S; Tanaka S; Chayama K
Helicobacter; 2014 Feb; 19(1):1-8. PubMed ID: 24215601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
